{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T19:40:38Z","timestamp":1692042038255},"reference-count":3,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1097\/dss.0000000000000948","type":"journal-article","created":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T16:35:08Z","timestamp":1477586108000},"page":"S259-S259","source":"Crossref","is-referenced-by-count":1,"title":["Special Issue: Deoxycholic Acid Injection Treatment for Reduction of Submental Fat"],"prefix":"10.1097","volume":"42","author":[{"given":"Jean","family":"Carruthers","sequence":"first","affiliation":[{"name":"Ophthalmology, University of British Columbia, Vancouver, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle","family":"Coleman","sequence":"additional","affiliation":[{"name":"Ophthalmology, University of British Columbia, Vancouver, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/lsm.20807","article-title":"Injectable treatments for adipose tissue: terminology, mechanism, and tissue interaction","volume":"41","author":"Rotunda","year":"2009","journal-title":"Lasers Surg Med"},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/bjd.12695","article-title":"Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study","volume":"170","author":"Rzany","year":"2014","journal-title":"Br J Dermatol"},{"issue":"4 Suppl 1","key":"R3-20230814","first-page":"123","article-title":"A Pooled analysis of the safety and efficacy results of the multicenter, double-blind, randomized, placebo-controlled phase 3 REFINE-1 and REFINE-2 trials of ATX-101, a submental contouring injectable drug for the reduction of submental fat","volume":"134","author":"Dayan","year":"2014","journal-title":"Plast Reconstr Surg"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00042728-201611001-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T19:06:18Z","timestamp":1692039978000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042728-201611001-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":3,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000000948","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}